Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?

By |2023-12-07T21:11:17+00:00September 27th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr.  The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for [...]